{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:19:20Z","timestamp":1783448360582,"version":"3.55.0"},"reference-count":34,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism is characterized by chronic parathyroid hormone excess, leading to hypercalcemia, increased bone turnover, and skeletal complications. Although osteoporosis is a common manifestation of these, the biochemical determinants of bone loss remain insufficiently defined. The roles of active vitamin D and renal phosphate handling require further clarification. This study aimed to identify biochemical determinants of osteoporosis in patients with primary hyperparathyroidism, with a particular focus on the contribution of calcitriol levels and renal phosphate handling. We further sought to evaluate their predictive performance in discriminating osteoporotic from non-osteoporotic individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 74 adults with primary hyperparathyroidism ineligible for surgery, assessing serum calcium, phosphate, vitamin D metabolites, parathormone, and 24 h urinary calcium. Renal phosphate handling was estimated by TMP\/GFR. Logistic regression and ROC analyses identified independent predictors and optimal cutoff values for osteoporosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Osteoporosis was present in 33.8% of patients. Individuals with osteoporosis demonstrated significantly higher calcitriol levels and lower renal phosphate reabsorption, also in multivariate analysis, while serum calcium, phosphate, and 25-hydroxyvitamin D did not differ between groups. Receiver operating characteristic curve analysis identified clinically meaningful cutoff values for both parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Increased levels of the active form of vitamin D and impaired renal conservation of phosphate are independently associated with osteoporosis in primary hyperparathyroidism, outperforming traditional biochemical markers. Incorporating these measures into routine clinical assessment may improve identification of patients at high skeletal risk and enhance decision-making in the management of bone disease in primary hyperparathyroidism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-26-0118","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:08:46Z","timestamp":1775830126000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":0,"title":["Phosphate handling as a determinant of osteoporosis in primary hyperparathyroidism"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5511-5823","authenticated-orcid":true,"given":"Sebastian","family":"Szewczyk","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0584-7259","authenticated-orcid":false,"given":"Micha\u0142","family":"Popow","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Ambroziak","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2026070714062289400_bib1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2026070714062289400_bib2","doi-asserted-by":"crossref","first-page":"e1749","DOI":"10.1210\/clinem\/dgad267","article-title":"Incidence of primary hyperparathyroidism in the current era: have we finally reached a steady state?","volume":"108","author":"Wermers","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714062289400_bib3","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2026070714062289400_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12020-019-02099-1","article-title":"Risk factors for vertebral fracture in primary hyperparathyroidism","volume":"66","author":"Liu","year":"2019","journal-title":"Endocrine"},{"key":"2026070714062289400_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026070714062289400_bib6","article-title":"Health Report: Osteoporosis 2013\u20132024","author":"National Health Fund (NFZ), Poland","year":"2025"},{"key":"2026070714062289400_bib7","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"2026070714062289400_bib8","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714062289400_bib9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2022.18331","article-title":"Hypercalcemia: a review","volume":"328","author":"Walker","year":"2022","journal-title":"JAMA"},{"key":"2026070714062289400_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/000456329803500203","article-title":"Renal tubular reabsorption of phosphate (TmP\/GFR): indications and interpretation","volume":"35","author":"Payne","year":"1998","journal-title":"Ann Clin Biochem"},{"key":"2026070714062289400_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.2006.02680.x","article-title":"Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function","volume":"66","author":"Moosgaard","year":"2007","journal-title":"Clin Endocrinol"},{"key":"2026070714062289400_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2004.01422.x","article-title":"Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features","volume":"257","author":"Bilezikian","year":"2005","journal-title":"J Intern Med"},{"key":"2026070714062289400_bib13","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1210\/jc.2015-2022","article-title":"Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation","volume":"100","author":"Walker","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714062289400_bib14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2015-4218","article-title":"Effect of low vitamin D on volumetric bone mineral density, bone microarchitecture, and stiffness in primary hyperparathyroidism","volume":"101","author":"Walker","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714062289400_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","article-title":"Treatment of postmenopausal osteoporosis with calcitriol or calcium","volume":"326","author":"Tilyard","year":"1992","journal-title":"N Engl J Med"},{"key":"2026070714062289400_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1139\/cjpp-2014-0419","article-title":"Vitamin D3 analogs for the treatment of osteoporosis1","volume":"93","author":"Hagino","year":"2015","journal-title":"Can J Physiol Pharmacol"},{"key":"2026070714062289400_bib17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00198-009-1136-2","article-title":"The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review","volume":"21","author":"Peppone","year":"2010","journal-title":"Osteoporos Int"},{"key":"2026070714062289400_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/PL00005840","volume":"66","author":"Nuti","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"2026070714062289400_bib19","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1210\/jc.2018-02483","article-title":"Predictors of nephrolithiasis, osteoporosis, and mortality in primary hyperparathyroidism","volume":"104","author":"Reid","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714062289400_bib20","doi-asserted-by":"crossref","first-page":"e56019","DOI":"10.1371\/journal.pone.0056019","article-title":"1,25-Dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism","volume":"8","author":"Christensen","year":"2013","journal-title":"PLoS One"},{"key":"2026070714062289400_bib21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.eprac.2022.07.005","article-title":"Hypophosphatemia: a practical guide to evaluation and management","volume":"28","author":"Tebben","year":"2022","journal-title":"Endocr Pract"},{"key":"2026070714062289400_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1759720X18779761","article-title":"Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm","volume":"10","author":"Day","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2026070714062289400_bib23","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00467-012-2175-z","article-title":"Phosphate homeostasis and its role in bone health","volume":"27","author":"Penido","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"2026070714062289400_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1152\/ajpcell.00456.2004","article-title":"Parathyroid hormone treatment induces dissociation of type IIa Na-P i cotransporter-Na\/H exchanger regulatory factor-1 complexes","volume":"289","author":"D\u00e9liot","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026070714062289400_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14740\/jem847","article-title":"Assessment and therapy of five hundred five patients with primary hyperparathyroidism","volume":"13","author":"Tucci","year":"2023","journal-title":"J Endocrinol Metab"},{"key":"2026070714062289400_bib26","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40618-023-02064-w","article-title":"The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism","volume":"46","author":"D\u00fc\u011fer","year":"2023","journal-title":"J Endocrinol Investig"},{"key":"2026070714062289400_bib27","doi-asserted-by":"crossref","first-page":"E612","DOI":"10.1210\/clinem\/dgab676","article-title":"Serum phosphate: a neglected test in the clinical management of primary hyperparathyroidism","volume":"107","author":"Castellano","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714062289400_bib28","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s00198-016-3658-8","article-title":"Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis","volume":"27","author":"Lucato","year":"2016","journal-title":"Osteoporos Int"},{"key":"2026070714062289400_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1180183","article-title":"Prevalence of osteoporosis in patients with nephrolithiasis and vice versa: a cumulative analysis","volume":"14","author":"Jia","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026070714062289400_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s13062-025-00627-w","article-title":"Exploring the association between osteoporosis and kidney stones: a clinical to mechanistic translational study based on big data and bioinformatics","volume":"20","author":"Luo","year":"2025","journal-title":"Biol Direct"},{"key":"2026070714062289400_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-9343(90)90346-F","article-title":"Nephrolithiasis and bone involvement in primary hyperparathyroidism","volume":"89","author":"Silverberg","year":"1990","journal-title":"Am J Med"},{"key":"2026070714062289400_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0002-9610(75)90365-7","article-title":"Differential diagnosis of hypercalcemia by the chloride\/phosphate ratio","volume":"130","author":"Reeves","year":"1975","journal-title":"Am J Surg"},{"key":"2026070714062289400_bib33","article-title":"The chloride\/phosphate ratio combined with alkaline phosphatase as a valuable predictive marker for primary hyperparathyroidism in Chinese individuals","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"2026070714062289400_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/15\/4\/EC-26-0118.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/15\/4\/EC-26-0118.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-26-0118\/504492\/ec-26-0118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-26-0118\/504492\/ec-26-0118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:06:31Z","timestamp":1783447591000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/15\/4\/e260118\/75832\/Phosphate-handling-as-a-determinant-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-26-0118","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"e260118"}}